These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 27564112)

  • 1. Role of EGF/ERBB1 in the transcriptional regulation of the prolactin receptor independent of estrogen and prolactin in breast cancer cells.
    Kavarthapu R; Dufau ML
    Oncotarget; 2016 Oct; 7(40):65602-65613. PubMed ID: 27564112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Essential role of endogenous prolactin and CDK7 in estrogen-induced upregulation of the prolactin receptor in breast cancer cells.
    Kavarthapu R; Dufau ML
    Oncotarget; 2017 Apr; 8(16):27353-27363. PubMed ID: 28423697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolactin induces up-regulation of its cognate receptor in breast cancer cells via transcriptional activation of its generic promoter by cross-talk between ERα and STAT5.
    Kavarthapu R; Tsai Morris CH; Dufau ML
    Oncotarget; 2014 Oct; 5(19):9079-91. PubMed ID: 25193864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolactin receptor gene transcriptional control, regulatory modalities relevant to breast cancer resistance and invasiveness.
    Kavarthapu R; Dufau ML
    Front Endocrinol (Lausanne); 2022; 13():949396. PubMed ID: 36187116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Signal transducer and activator of transcription 5b, c-Src, and epidermal growth factor receptor signaling play integral roles in estrogen-stimulated proliferation of estrogen receptor-positive breast cancer cells.
    Fox EM; Bernaciak TM; Wen J; Weaver AM; Shupnik MA; Silva CM
    Mol Endocrinol; 2008 Aug; 22(8):1781-96. PubMed ID: 18550772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prolactin receptor transactivation domain is associated with steroid hormone receptor expression and malignant progression of breast cancer.
    Fiorillo AA; Medler TR; Feeney YB; Wetz SM; Tommerdahl KL; Clevenger CV
    Am J Pathol; 2013 Jan; 182(1):217-33. PubMed ID: 23159947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crosstalk between PRLR and EGFR/HER2 Signaling Pathways in Breast Cancer.
    Kavarthapu R; Anbazhagan R; Dufau ML
    Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal growth factor receptor signalling in human breast cancer cells operates parallel to estrogen receptor α signalling and results in tamoxifen insensitive proliferation.
    Moerkens M; Zhang Y; Wester L; van de Water B; Meerman JH
    BMC Cancer; 2014 Apr; 14():283. PubMed ID: 24758408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fulvestrant regulates epidermal growth factor (EGF) family ligands to activate EGF receptor (EGFR) signaling in breast cancer cells.
    Zhang X; Diaz MR; Yee D
    Breast Cancer Res Treat; 2013 Jun; 139(2):351-60. PubMed ID: 23686416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel estradiol/estrogen receptor alpha-dependent transcriptional mechanism controls expression of the human prolactin receptor.
    Dong J; Tsai-Morris CH; Dufau ML
    J Biol Chem; 2006 Jul; 281(27):18825-36. PubMed ID: 16651265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal growth factor and estrogen act by independent pathways to additively promote the release of the angiogenic chemokine CXCL8 by breast tumor cells.
    Haim K; Weitzenfeld P; Meshel T; Ben-Baruch A
    Neoplasia; 2011 Mar; 13(3):230-43. PubMed ID: 21390186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EBP50 inhibits EGF-induced breast cancer cell proliferation by blocking EGFR phosphorylation.
    Yao W; Feng D; Bian W; Yang L; Li Y; Yang Z; Xiong Y; Zheng J; Zhai R; He J
    Amino Acids; 2012 Nov; 43(5):2027-35. PubMed ID: 22476347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complex formation and interactions between transcription factors essential for human prolactin receptor gene transcription.
    Kang JH; Tsai-Morris CH; Dufau ML
    Mol Cell Biol; 2011 Aug; 31(16):3208-22. PubMed ID: 21670145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel taspine derivative, HMQ1611, inhibits breast cancer cell growth via estrogen receptor α and EGF receptor signaling pathways.
    Zhan Y; Zhang Y; Liu C; Zhang J; Smith WW; Wang N; Chen Y; Zheng L; He L
    Cancer Prev Res (Phila); 2012 Jun; 5(6):864-73. PubMed ID: 22496388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prolactin receptor mediates HOXA1-stimulated oncogenicity in mammary carcinoma cells.
    Hou L; Xu B; Mohankumar KM; Goffin V; Perry JK; Lobie PE; Liu DX
    Int J Oncol; 2012 Dec; 41(6):2285-95. PubMed ID: 23064471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermal growth factor receptor cross-talks with ligand-occupied estrogen receptor-alpha to modulate both lactotroph proliferation and prolactin gene expression.
    Chen S; Bangaru ML; Sneade L; Dunckley JA; Ben-Jonathan N; Kansra S
    Am J Physiol Endocrinol Metab; 2009 Aug; 297(2):E331-9. PubMed ID: 19470835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen receptor-alpha mediates the epidermal growth factor-stimulated prolactin expression and release in lactotrophs.
    Ben-Jonathan N; Chen S; Dunckley JA; LaPensee C; Kansra S
    Endocrinology; 2009 Feb; 150(2):795-802. PubMed ID: 18832099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen negatively regulates epidermal growth factor (EGF)-mediated signal transducer and activator of transcription 5 signaling in human EGF family receptor-overexpressing breast cancer cells.
    Boerner JL; Gibson MA; Fox EM; Posner ED; Parsons SJ; Silva CM; Shupnik MA
    Mol Endocrinol; 2005 Nov; 19(11):2660-70. PubMed ID: 15976008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen utilization of IGF-1-R and EGF-R to signal in breast cancer cells.
    Song RX; Chen Y; Zhang Z; Bao Y; Yue W; Wang JP; Fan P; Santen RJ
    J Steroid Biochem Mol Biol; 2010 Feb; 118(4-5):219-30. PubMed ID: 19815064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgen receptor promotes tamoxifen agonist activity by activation of EGFR in ERα-positive breast cancer.
    Ciupek A; Rechoum Y; Gu G; Gelsomino L; Beyer AR; Brusco L; Covington KR; Tsimelzon A; Fuqua SA
    Breast Cancer Res Treat; 2015 Nov; 154(2):225-37. PubMed ID: 26487496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.